The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial
Open accessAbstract
IMPORTANCE: Iron deficiency is present in approximately 50% of patients with heart failure with reduced left ventricular ejection fraction (HFrEF) and is an independent predictor of reduced functional capacity and mortality. However, the efficacy of inexpensive readily available oral iron supplementation in heart failure is unknown. OBJECTIVE: To test whether therapy with oral iron improves peak exercise capacity in patients with HFrEF and iron deficiency. DESIGN, SETTING, AND PARTICIPANTS: Phase 2, double-blind, placebo-controlled randomized clinical trial of patients with HFrEF (<40%) and iron deficiency, defined as a serum ferritin level of 15 to 100 ng/mL or a serum ferritin level of 101 to 299 ng/mL with transferrin saturation of less than 20%. Participants were enrolled between September 2014 and November 2015 at 23 US sites. INTERVENTIONS: Oral iron polysaccharide (n = 111) or placebo (n = 114), 150 mg twice daily for 16 weeks. MAIN OUTCOMES AND MEASURES: The primary end point was a change in peak oxygen uptake (V̇o2) from baseline to 16 weeks. Secondary end points were change in 6-minute walk distance, plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels, and health status as assessed by Kansas City Cardiomyopathy Questionnaire (KCCQ, range 0-100, higher scores reflect better quality of life). RESULTS: Among 225 randomized participants (median age, 63 years; 36% women) 203 completed the study. The median baseline peak V̇o2 was 1196 mL/min (interquartile range [IQR], 887-1448 mL/min) in the oral iron group and 1167 mL/min (IQR, 887-1449 mL/min) in the placebo group. The primary end point, change in peak V̇o2 at 16 weeks, did not significantly differ between the oral iron and placebo groups (+23 mL/min vs -2 mL/min; difference, 21 mL/min [95% CI, -34 to +76 mL/min]; P = .46). Similarly, at 16 weeks, there were no significant differences between treatment groups in changes in 6-minute walk distance (-13 m; 95% CI, -32 to 6 m), NT-proBNP levels (159; 95% CI, -280 to 599 pg/mL), or KCCQ score (1; 95% CI, -2.4 to 4.4), all P > .05. CONCLUSIONS AND RELEVANCE: Among participants with HFrEF with iron deficiency, high-dose oral iron did not improve exercise capacity over 16 weeks. These results do not support use of oral iron supplementation in patients with HFrEF. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT02188784.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803 · cited 2×
“Left ventricular ejection fraction, median (IQR), % 25 (20-34) 25 (20-33) 25 (20-34)”
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
Andrews, N. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912233412607 · Cited by 2,130
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
Anker, S. D., Comin Colet, J., Filippatos, G., Willenheimer, R., Dickstein, K., Drexler, H., Lüscher, T. F., Bart, B., Banasiak, W., Niegowska, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908355 · Cited by 2,083
Green, C. P., Porter, C. B., Bresnahan, D. R., & Spertus, J. A. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00531-3 · Cited by 1,827
Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003) · Blood · doi:10.1182/blood-2002-10-3235 · Cited by 1,417
Dysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis
Makker, J., Hanif, A., Bajantri, B., & Chilimuri, S. (2015) · Case Reports in Gastroenterology · doi:10.1159/000373883 · Cited by 1,351
Ponikowski, P., van Veldhuisen, D. J., Comin-Colet, J., Ertl, G., Komajda, M., Mareev, V., McDonagh, T., Parkhomenko, A., Tavazzi, L., Levesque, V., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu385 · Cited by 1,242
Nicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., & Vaulont, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215686 · Cited by 1,214
Haas, J. D., & Brownlie, T. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.2.676s · Cited by 1,186
Hepcidin and iron regulation, 10 years later
Ganz, T. (2011) · Blood · doi:10.1182/blood-2011-01-258467 · Cited by 962
Iron deficiency in chronic heart failure: an international pooled analysis
Klip, I. T., Comin-Colet, J., Voors, A. A., Ponikowski, P., Enjuanes, C., Banasiak, W., Lok, D. J., Rosentryt, P., Torrens, A., Polonski, L., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.01.017 · Cited by 736
Okonko, D. O., Grzeslo, A., Witkowski, T., Mandal, A. K. J., Slater, R. M., Roughton, M., Foldes, G., Thum, T., Majda, J., Banasiak, W., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.036 · Cited by 569
Cardiopulmonary Exercise Testing in Heart Failure
Malhotra, R., Bakken, K., D’Elia, E., & Lewis, G. D. (2016) · JACC: Heart Failure · doi:10.1016/j.jchf.2016.03.022 · Cited by 451
Self-citationIron uptake and metabolism in the new millennium
Dunn, L. L., Rahmanto, Y. S., & Richardson, D. R. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.12.003 · Cited by 420
Toblli, J. E., Lombraña, A., Duarte, P., & Di Gennaro, F. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.029 · Cited by 415
Swank, A. M., Horton, J., Fleg, J. L., Fonarow, G. C., Keteyian, S., Goldberg, L., Wolfel, G., Handberg, E. M., Bensimhon, D., Illiou, M.-C., et al. (2012) · Circulation: Heart Failure · doi:10.1161/circheartfailure.111.965186 · Cited by 374
Iron Deficiency Predicts Impaired Exercise Capacity in Patients With Systolic Chronic Heart Failure
Jankowska, E. A., Rozentryt, P., Witkowska, A., Nowak, J., Hartmann, O., Ponikowska, B., Borodulin-Nadzieja, L., von Haehling, S., Doehner, W., Banasiak, W., et al. (2011) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2011.08.003 · Cited by 281
Beck-da-Silva, L., Piardi, D., Soder, S., Rohde, L. E., Pereira-Barretto, A. C., de Albuquerque, D., Bocchi, E., Vilas-Boas, F., Moura, L. Z., Montera, M. W., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.04.181 · Cited by 244
Myocardial Iron Content and Mitochondrial Function in Human Heart Failure: A Direct Tissue Analysis
Melenovsky, V., Petrak, J., Mracek, T., Benes, J., Borlaug, B. A., Nuskova, H., Pluhacek, T., Spatenka, J., Kovalcikova, J., Drahota, Z., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.640 · Cited by 231
Dong, F., Zhang, X., Culver, B., Chew, H. G., Kelley, R. O., & Ren, J. (2005) · Clinical Science · doi:10.1042/cs20040278 · Cited by 171
van Santen, S., van Dongen-Lases, E. C., de Vegt, F., Laarakkers, C. M., van Riel, P. L. C. M., van Ede, A. E., & Swinkels, D. W. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30623 · Cited by 153
Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin
Wingard, R. L., Parker, R. A., Ismail, N., & Hakim, R. M. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90105-1 · Cited by 139
Serum hepcidin levels and iron parameters in children with iron deficiency
Choi, H. S., Song, S. H., Lee, J. H., Kim, H., & Yang, H. R. (2012) · The Korean Journal of Hematology · doi:10.5045/kjh.2012.47.4.286 · Cited by 80
Lewis, G. D., Semigran, M. J., Givertz, M. M., Malhotra, R. K., Anstrom, K. J., Hernandez, A. F., Shah, M., & Braunwald, E. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.000345 · Cited by 65
Self-citationAnemia: a comprehensive global estimate
Pasricha, S. (2014) · Blood · doi:10.1182/blood-2013-12-543405 · Cited by 64
Hepcidin and iron metabolism: From laboratory to clinical implications
Franchini, M., Montagnana, M., & Lippi, G. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.07.003 · Cited by 63
Molecular Changes in Myocardium in the Course of Anemia or Iron Deficiency
Jankowska, E. A., & Ponikowski, P. P. (2010) · Heart Failure Clinics · doi:10.1016/j.hfc.2010.03.003 · Cited by 52
Chatterjee, N. A., Murphy, R. M., Malhotra, R. K., Dhakal, B. P., Baggish, A. L., Pappagianopoulos, P. P., Hough, S. S., Semigran, M. J., & Lewis, G. D. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.000157 · Cited by 50
Self-citationJacobs, P., Fransman, D., & Coghlan, P. (1993) · Journal of Clinical Apheresis · doi:10.1002/jca.2920080207 · Cited by 39
L'hepcidine et le métabolisme du fer
Delaby, C., Deybach, J., & Beaumont, C. (2007) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2007.03.009 · Cited by 16
Cited by
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
Self-citation2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Self-citationHeidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
Self-citation2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
Self-citationAuthors/Task Force Members:, McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2333 · Cited by 2,171
Self-citation
Metadata
- Authors
- Lewis, G. D., Malhotra, R., Hernandez, A. F., McNulty, S. E., Smith, A., Felker, G. M., Tang, W. H. W., LaRue, S. J., Redfield, M. M., Semigran, M. J., Givertz, M. M., Van Buren, P., Whellan, D., Anstrom, K. J., Shah, M. R., Desvigne-Nickens, P., Butler, J., Braunwald, E., & for the NHLBI Heart Failure Clinical Research Network
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2017-05-16
- Volume
- 317
- Issue
- 19
- Pages
- 1958
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2614710189
- Cited by
- 480
- References
- 32
- FWCI
- 28.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.